Literature DB >> 11964828

Sequential antibiotic therapy.

Gavin D. Barlow1, Dilip Nathwani.   

Abstract

Antimicrobials are an important source of hospital expenditure. Traditionally, severe bacterial infections have been treated initially with intravenous antibiotics, followed by physician-directed switch to oral therapy. Unfortunately this approach results in unnecessary prolongation of intravenous treatment, with all its inherent disadvantages. Sequential antibiotic therapy, however, ensures an early switch to the oral route when the patient is clinically stable. This increasingly employed strategy is safe and results in improved quality and cost-effectiveness of health care. To ensure timely and appropriate switch, such programmes need to be underpinned by clear guidelines and supported by a multidisciplinary team. In the future, key questions, such as what is the optimal time of switch for specific infections, and can conditions such as osteomyelitis and endocarditis be efficaciously treated with oral therapy, need to be answered. Only then will clinicians be able to practise evidence-based infection management incorporating sequential antimicrobial therapy.

Entities:  

Year:  2000        PMID: 11964828     DOI: 10.1097/00001432-200012000-00004

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  7 in total

Review 1.  Addressing Concerns about Changing the Route of Antimicrobial Administration from Intravenous to Oral in Adult Inpatients.

Authors:  Lizanne Béïque; Rosemary Zvonar
Journal:  Can J Hosp Pharm       Date:  2015 Jul-Aug

Review 2.  Is antibiotic resistance a problem? A practical guide for hospital clinicians.

Authors:  G Barlow; D Nathwani
Journal:  Postgrad Med J       Date:  2005-11       Impact factor: 2.401

Review 3.  Proposed antithrombotic strategy for acute ischemic stroke with large-artery atherosclerosis: focus on patients with high-risk transient ischemic attack and mild-to-moderate stroke.

Authors:  Xiaowen Hou; Huisheng Chen
Journal:  Ann Transl Med       Date:  2020-01

4.  Delicate Metabolic Control and Coordinated Stress Response Critically Determine Antifungal Tolerance of Candida albicans Biofilm Persisters.

Authors:  Peng Li; Chaminda J Seneviratne; Emanuele Alpi; Juan A Vizcaino; Lijian Jin
Journal:  Antimicrob Agents Chemother       Date:  2015-07-20       Impact factor: 5.191

5.  Factors associated with adverse postoperative outcomes in patients with long bone post-traumatic osteomyelitis.

Authors:  Vivek Chadayammuri; Benoit Herbert; Jiandong Hao; Andreas Mavrogenis; Juan C Quispe; Ji Wan Kim; Heather Young; Mark Hake; Cyril Mauffrey
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-04-28

6.  Microbiological Characterization of VNRX-5236, a Broad-Spectrum β-Lactamase Inhibitor for Rescue of the Orally Bioavailable Cephalosporin Ceftibuten as a Carbapenem-Sparing Agent against Strains of Enterobacterales Expressing Extended-Spectrum β-Lactamases and Serine Carbapenemases.

Authors:  Cassandra L Chatwin; Jodie C Hamrick; Robert E L Trout; Cullen L Myers; Susan M Cusick; William J Weiss; Mark E Pulse; Luigi Xerri; Christopher J Burns; Gregory Moeck; Denis M Daigle; Kaitlyn John; Tsuyoshi Uehara; Daniel C Pevear
Journal:  Antimicrob Agents Chemother       Date:  2021-07-16       Impact factor: 5.191

7.  Modification of empirical antimicrobial regimens in large animal medicine.

Authors:  Laurel Redding; Haley Grunwald; Stephen Cole; Shelley Rankin; Rose Nolen-Walston
Journal:  Vet Rec       Date:  2020-09-29       Impact factor: 2.695

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.